Merck's molnupiravir not as effective as initially found

Discussion in 'Coronavirus Pandemic Discussions' started by CenterField, Nov 26, 2021.

PF does not allow misinformation. However, please note that posts could occasionally contain content in violation of our policies prior to our staff intervening. We urge you to seek reliable alternate sources to verify information you read in this forum.

  1. CenterField

    CenterField Well-Known Member Past Donor

    Joined:
    Jul 21, 2020
    Messages:
    9,738
    Likes Received:
    8,378
    Trophy Points:
    113
    Gender:
    Male
    Merck now has the full data of its molnupiravir trial. The interim results had suggested an efficacy of 50% reduction in hospitalizations and death but the complete set of data ended up with 30% efficacy, which is disappointing.

    Interim data for the Pfizer one had an efficacy of 89%. Let's hope that one doesn't also show a drop in efficacy once the full data are in.
     

Share This Page